Current Trends in Chemotherapy in the Treatment of Metastatic Prostate Cancer
J Zhao, BJ Guercio, D Sahasrabudhe - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer is the second most frequently occurring cancer in men,
and patients with advanced prostate cancer have poor long-term survival. Chemotherapy is …
and patients with advanced prostate cancer have poor long-term survival. Chemotherapy is …
The performance and limitations of PCA3, TMPRSS2: ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics
Abstract Background Prostate cancer (PCa) is the second most commonly diagnosed cancer
in men. To date, the role of the combined application of long non-coding RNAs (PCA3 …
in men. To date, the role of the combined application of long non-coding RNAs (PCA3 …
High levels of DEPDC1B predict shorter biochemical recurrence‑free survival of patients with prostate cancer
S Bai, T Chen, T Du, X Chen, Y Lai… - Oncology …, 2017 - spandidos-publications.com
DEP domain‑containing protein 1B (DEPDC1B) has been reported to serve important
functions in breast cancer and non‑small cell lung cancer. However, its involvement in the …
functions in breast cancer and non‑small cell lung cancer. However, its involvement in the …
[HTML][HTML] Limited improvement in prostate cancer mortality-to-incidence ratios in countries with high health care expenditures
SC Wang, L Chan, TY Hsieh, CH Wang… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Prostate cancer mortality-to-incidence ratios (MIRs) are associated with the level of available
healthcare. However, no data are currently available to show an association between …
healthcare. However, no data are currently available to show an association between …
Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: A study based on meta‑analyses and bioinformatics
ZC Xie, JC Huang, LJ Zhang… - Molecular …, 2018 - spandidos-publications.com
Prostate cancer (PCa) remains a principal issue to be addressed in male cancer‑associated
mortality. Therefore, the present study aimed to examine the clinical value and associated …
mortality. Therefore, the present study aimed to examine the clinical value and associated …
Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications
Background: Papillary thyroid cancer (PTC) is the most common type of thyroid cancer.
Unlike most cancers, its incidence has dramatically increased in the last decades mainly …
Unlike most cancers, its incidence has dramatically increased in the last decades mainly …
Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy
F Yan, X Li, N Li, R Zhang, Q Wang, Y Ru, X Hao, J Ni… - Cancer letters, 2017 - Elsevier
Highly efficient target therapy is urgently needed for prostate cancer with overexpression of γ-
seminoprotein (γ-SM). Recent studies indicated that mesenchymal stem cells (MSCs) are …
seminoprotein (γ-SM). Recent studies indicated that mesenchymal stem cells (MSCs) are …
Survival Analysis and a Novel Nomogram Model for Progression‐Free Survival in Patients with Prostate Cancer
Y Han, X Wen, D Chen, X Li, Q Leng, Y Wen… - Journal of …, 2022 - Wiley Online Library
Background. This study sought to perform a survival analysis and construct a prognostic
nomogram model based on the Gleason grade, total prostate‐specific antigen (tPSA) …
nomogram model based on the Gleason grade, total prostate‐specific antigen (tPSA) …
大连地区男性年龄相关前列腺特异性抗原参考值范围
蔡凯， 刘志宇， 王梁， 戴志红， 苏婕 - 中国医科大学学报, 2017 - cqvip.com
目的分析大连地区男性血清前列腺特异性抗原(PSA) 水平, 探讨建立本地区男性年龄相关PSA
参考值范围, 以提高PSA 对本地区早期前列腺癌诊断的准确性. 方法2011 年1 月至2016 年6 月 …
参考值范围, 以提高PSA 对本地区早期前列腺癌诊断的准确性. 方法2011 年1 月至2016 年6 月 …
成年人股骨干骨折双钢板锁定内固定治疗的疗效分析
王臣， 肖万军 - 中国医科大学学报, 2017 - cqvip.com
目的探讨成年人股骨干骨折双钢板锁定内固定治疗的疗效以及预后. 方法选取2014 年2
月至2016 年3 月在我院应用锁定加压钢板治疗的股骨干骨折80 例, 随机分为观察组和对照组 …
月至2016 年3 月在我院应用锁定加压钢板治疗的股骨干骨折80 例, 随机分为观察组和对照组 …